Correction Notice: Monitoring Intestinal Organoid–Derived Monolayer Barrier Functions with Electric Cell–Substrate Impedance Sensing (ECIS)

Autor: Sarah Ouahoud, Francesca Giugliano, Vanesa Muncan

Publikováno v: Bio-Protocol, Vol 14, Iss 15 (2024)

Externí odkaz: https://doaj.org/article/1af0fe7b84a34048929a50ec04835d01

Monitoring Intestinal Organoid–Derived Monolayer Barrier Functions with Electric Cell–Substrate Impedance Sensing (ECIS)

Autor: Sarah Ouahoud, Francesca Giugliano, Vanesa Muncan

Publikováno v: Bio-Protocol, Vol 14, Iss 5 (2024)

The measurement of transepithelial electrical resistance across confluent cell monolayer systems is the most commonly used technique to study intestinal barrier development and integrity. Electric cell substrate impedance sensing (ECIS) is a real-tim

Externí odkaz: https://doaj.org/article/d6543e83812f43a9b1262785b7230754

The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis

Autor: Liesbeth M. Hondelink, Anne M.R. Schrader, Golzar Asri Aghmuni, Nienke Solleveld-Westerink, Anne-Marie Cleton-Jansen, Demi van Egmond, Arnoud Boot, Sarah Ouahoud, Midia N. Khalifa, Suk Wai Lam, Hans Morreau, Judith V.M.G. Bovee, Tom van Wezel, Danielle Cohen

Publikováno v: European Journal of Cancer, 173, 229-237. ELSEVIER SCI LTD

Introduction: Since the approval of neurotrophic tropomyosin receptor kinase (NTRK) tyrosine kinase inhibitors for fist-line advanced stage pan-cancer therapy, pathologists and molecular biologists have been facing a complex question: how should the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe9776ba1df018ff9a159cd4817dcee
http://hdl.handle.net/1887/3564278

Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4

Autor: Tom van Wezel, Ron M. C. Herings, Britt van Vliet, Lukas J. A. C. Hawinkels, James C. H. Hardwick, Rutger J. Jacobs, Ludmilla L. Kodach, Philip W. Voorneveld, Sarah Ouahoud, Hans Morreau, Marije Slingerland, Esther Bastiaannet, Hein Putter, Nikki L. Weil, Lennart R A van der Burg

Publikováno v: Ouahoud, S, Jacobs, R J, Kodach, L L, Voorneveld, P W, Hawinkels, L J A C, Weil, N L, van Vliet, B, Herings, R M, van der Burg, L R A, van Wezel, T, Morreau, H, Slingerland, M, Bastiaannet, E, Putter, H & Hardwick, J C H 2022, ' Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4 ', British Journal of Cancer, vol. 126, no. 2, pp. 297-301 . https://doi.org/10.1038/s41416-021-01604-6
British Journal of Cancer. SPRINGERNATURE
British Journal of Cancer
British Journal of Cancer, 126(2), 297-301. Nature Publishing Group
Br J Cancer

BACKGROUND: Long-term use of statins is associated with a small reduced risk of colorectal cancer but their mechanism of action is not well understood. While they are generally believed to act on KRAS, we have previously proposed that they act via in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eee94a4827fa764a30634a966aa9f83e
https://hdl.handle.net/1887/3264145

Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer

Autor: Sarah, Ouahoud, Philip W, Voorneveld, Lennart R A, van der Burg, Eveline S M, de Jonge-Muller, Mark J A, Schoonderwoerd, Madelon, Paauwe, Thijs, de Vos, Sophie, de Wit, Gabi W, van Pelt, Wilma E, Mesker, Lukas J A C, Hawinkels, James C H, Hardwick

Publikováno v: Oncogene. 39(12)

Patients with the mesenchymal subtype colorectal cancer (CRC) have a poor prognosis, in particular patients with stroma-rich tumors and aberrant SMAD4 expression. We hypothesized that interactions between SMAD4-deficient CRC cells and cancer-associat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::79f82348abbbeec8fb1a89fd49eeeede
https://pubmed.ncbi.nlm.nih.gov/31974473